Growth Metrics

LifeMD (LFMD) Equity Average (2016 - 2025)

LifeMD (LFMD) has disclosed Equity Average for 13 consecutive years, with $12.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average rose 293.42% year-over-year to $12.2 million, compared with a TTM value of $12.2 million through Dec 2025, up 293.42%, and an annual FY2025 reading of $7.8 million, up 563.66% over the prior year.
  • Equity Average was $12.2 million for Q4 2025 at LifeMD, up from $1.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $16.9 million in Q1 2022 and bottomed at -$13.6 million in Q2 2023.
  • Average Equity Average over 5 years is -$1.8 million, with a median of -$2.7 million recorded in 2021.
  • The sharpest move saw Equity Average crashed 2471.92% in 2023, then surged 753.51% in 2025.
  • Year by year, Equity Average stood at $1.5 million in 2021, then plummeted by 534.11% to -$6.6 million in 2022, then surged by 47.92% to -$3.4 million in 2023, then crashed by 83.48% to -$6.3 million in 2024, then surged by 293.42% to $12.2 million in 2025.
  • Business Quant data shows Equity Average for LFMD at $12.2 million in Q4 2025, $1.8 million in Q3 2025, and $2.1 million in Q2 2025.